B Cells in Mice in Inducing Autoreactive Antibodies Against β and Ig α Comparative Effects of Human Ig
暂无分享,去创建一个
Carmay Lim | Tse-Wen Chang | Jim J. C. Sheu | Tammy M. K. Cheng | Huan Y. Chen | C. Lim | J. Sheu | Huan-Yuan Chen | T. Chang
[1] J. Vostal,et al. Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin , 2002, BMC Cell Biology.
[2] D. Scott,et al. B‐cell receptor and Fas‐mediated signals for life and death , 2000, Immunological reviews.
[3] M. Reth,et al. Differential signaling through the Ig‐α and Ig‐β components of the B cell antigen receptor , 1993 .
[4] A. Poupon,et al. The immunoglobulin fold family: sequence analysis and 3D structure comparisons. , 1999, Protein engineering.
[5] M. Cragg,et al. Signaling antibodies in cancer therapy. , 1999, Current opinion in immunology.
[6] B. A. Jameson,et al. The antigenic index: a novel algorithm for predicting antigenic determinants , 1988, Comput. Appl. Biosci..
[7] T. Kurosaki,et al. Molecular mechanisms in B cell antigen receptor signaling. , 1997, Current opinion in immunology.
[8] G. Chelvanayagam,et al. Peptide mimics of a tumor antigen induce functional cytotoxic T cells , 1998, Nature Biotechnology.
[9] M. Mamula,et al. Molecular mimicry and the role of B lymphocytes in the processing of autoantigens , 2000, Cellular and Molecular Life Sciences CMLS.
[10] M. Glennie,et al. Clinical trials of antibody therapy. , 2000, Immunology today.
[11] T W Chang,et al. Human mb-1 gene: complete cDNA sequence and its expression in B cells bearing membrane Ig of various isotypes. , 1992, Journal of immunology.
[12] D. Campana,et al. Mutations in Igα (CD79a) result in a complete block in B-cell development , 1999 .
[13] M. Nussenzweig,et al. Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta , 1993, The Journal of experimental medicine.
[14] V. Verhasselt,et al. From autoimmune responses to autoimmune disease: what is needed? , 2001, Journal of autoimmunity.
[15] L. Nathanson,et al. Letter: Treatment of malignant melanoma. , 1974, Lancet.
[16] B. Diamond,et al. Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[17] A. Nechansky,et al. Inhibition of Antigen-Induced Mediator Release from IgE-Sensitized Cells by a Monoclonal Anti-FcεRI α-Chain Receptor Antibody: Implications for the Involvement of the Membrane-Proximal α-Chain Region in FcεRI-Mediated Cell Activation1 , 2001, The Journal of Immunology.
[18] M. Neuberger,et al. The B-cell antigen receptor of the five immunoglobulin classes , 1991, Nature.
[19] J. V. van Dongen,et al. The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. , 1991, Journal of immunology.
[20] Cheever,et al. Human HER‐2/neu protein immunization circumvents tolerance to rat neu: a vaccine strategy for ‘self’ tumour antigens , 1998, Immunology.
[21] J. Samaridis,et al. Fetal liver pro-B and pre-B lymphocyte clones: expression of lymphoid-specific genes, surface markers, growth requirements, colonization of the bone marrow, and generation of B lymphocytes in vivo and in vitro , 1992, Molecular and cellular biology.
[22] C. Jenkin,et al. Antigenic Cross-Reaction between Host and Parasite as a Possible Cause of Pathogenicity , 1962, Nature.
[23] C Chothia,et al. Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains. , 1994, Journal of molecular biology.
[24] E. Jaffe,et al. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. , 1995, Blood.
[25] A. Theofilopoulos. The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition. , 1995, Immunology today.
[26] H. Korn,et al. Different patterns of calcium signaling triggered through two components of the B lymphocyte antigen receptor. , 1994, The Journal of biological chemistry.
[27] J. Ledbetter,et al. Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. , 1998, Blood.
[28] P. Santamaria,et al. Effector lymphocytes in autoimmunity. , 2001, Current Opinion in Immunology.
[29] R. Scheuermann,et al. Tumour dormancy and cell signalling--III: Role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells. , 1995, Therapeutic immunology.
[30] S. Arbogast,et al. Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen--first results. , 1997, Immunology letters.
[31] J A Hardin,et al. Induction of autoreactive B cells allows priming of autoreactive T cells , 1991, The Journal of experimental medicine.
[32] M. Atassi,et al. Antibodies against protein antigenic sites that are identical in the homologous protein of the immunized animal. Autoreactivity in rabbits of antibodies to sperm-whale myoglobin. , 1977, Biochimica et biophysica acta.
[33] C. Terhorst,et al. Cloning and sequencing of the cDNA encoding the human homologue of the murine immunoglobulin‐associated protein B29 , 1992, European journal of immunology.
[34] C. Reutelingsperger,et al. Expression on B Cells Undergoing Apoptosis Annexin V for Flow Cytometric Detection of Phosphatidylserine , 2022 .
[35] R. Damian. Molecular Mimicry: Antigen Sharing by Parasite and Host and Its Consequences , 1964, The American Naturalist.
[36] M. Cragg,et al. The development of anti-CD79 monoclonal antibodies for treatment of B-cell neoplastic disease. , 1995, Therapeutic immunology.
[37] B. Rost,et al. Combining evolutionary information and neural networks to predict protein secondary structure , 1994, Proteins.
[38] M. Oldstone. Molecular mimicry and autoimmune disease , 1987, Cell.
[39] J. Nerup,et al. YERSINIA ENTEROCOLITICA INFECTION AND THYROID DISORDERS , 1974 .
[40] J. Kurtzke. Epidemiologic evidence for multiple sclerosis as an infection , 1993, Clinical Microbiology Reviews.
[41] V. Apostolopoulos,et al. Mimics and cross reactions of relevance to tumour immunotherapy. , 1999, Vaccine.
[42] C Haanen,et al. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.
[43] H. Ha,et al. Molecular cloning and expression pattern of a human gene homologous to the murine mb-1 gene. , 1992, Journal of immunology.
[44] J. Sheu,et al. Inducing specific reactivity against B cells in mice by immunizing with an Fc fusion protein containing self-Igβ , 2002, Cancer Immunology, Immunotherapy.
[45] C. Janeway,et al. Breaking T cell tolerance with foreign and self co-immunogens. A study of autoimmune B and T cell epitopes of cytochrome c. , 1992, Journal of immunology.
[46] M. Menser,et al. RUBELLA INFECTION AND DIABETES MELLITUS , 1978, The Lancet.
[47] M. Reth. Antigen receptors on B lymphocytes. , 1992, Annual review of immunology.
[48] Rolf Apweiler,et al. Representation of functional information in the SWISS-PROT Data Bank , 1999, Bioinform..
[49] S. Noskov,et al. Free energy decomposition of protein-protein interactions. , 2001, Biophysical journal.
[50] B. Rost,et al. Prediction of protein secondary structure at better than 70% accuracy. , 1993, Journal of molecular biology.
[51] A. Kazlauskas,et al. The B cell antigen receptor complex: association of Ig-alpha and Ig-beta with distinct cytoplasmic effectors. , 1992, Science.
[52] J L Sussman,et al. Protein Data Bank archives of three-dimensional macromolecular structures. , 1997, Methods in enzymology.
[53] Fu-Tong Liu,et al. Monoclonal Antibodies against the CεmX Domain of Human Membrane-Bound IgE and Their Potential Use for Targeting IgE-Expressing B Cells , 2002, International Archives of Allergy and Immunology.
[54] J. V. van Dongen,et al. Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines. , 1993, Leukemia.
[55] D. Fearon,et al. Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors. , 1998, Journal of immunology.